REGEN-COVยฎ for Treatment of Hospitalized Patients with Covid-19
Background Hospitalized patients with Covid-19 experience high mortality rates, ranging from 10-30%. Casirivimab and imdevimab (REGEN-COVยฎ) is authorized in various jurisdictions for use in outpati...
medrxiv.org